Skip to content

PTC Therapeutics PTCT Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$2.81M$15.9M+125%-$64.85M-107%$866.56M+1,415%
$15.41M+19.5%$12.9M+16.1%$11.11M+46.5%$7.58M+5.0%$7.22M+6.8%
$23.42M+26.5%$18.52M-4.7%$19.43M+4.8%$18.54M+2.7%$18.06M+4.8%
-$59.04M$870.1M+3,000%
$1.2M-49.6%$2.37M-31.1%$3.45M+162%$1.32M-23.6%$1.72M-54.2%
-$93.74M$0+100%-$289.62M+31.4%-$422.01M-129%-$184.36M-169%
$6.4M-97.9%$302.5M+1,888%$15.22M+284%$3.96M-57.9%$9.41M-64.5%
-$147.9M-147%$312.03M+190%-$346.77M$700.55M+174%
-$60.24M$868.38M+2,671%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does PTC Therapeutics generate?
PTC Therapeutics (PTCT) generated $704.1M in operating cash flow over the trailing twelve months.
What is PTC Therapeutics's free cash flow?
After $8.3M of capital expenditures, PTC Therapeutics's free cash flow was $696.9M over the trailing twelve months, up 637.5% year over year.
Where does PTC Therapeutics's cash flow data come from?
Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.